UCNP-based photoluminescent nanomedicines for targeted imaging and theranostics of cancer

26Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Theranostic approach is currently among the fastest growing trends in cancer treatment. It implies the creation of multifunctional agents for simultaneous precise diagnosis and targeted impact on tumor cells. A new type of theranostic complexes was created based on NaYF4: Yb,Tm upconversion nanoparticles coated with polyethylene glycol and functionalized with the HER2-specific recombinant targeted toxin DARPin-LoPE. The obtained agents bind to HER2-overexpressing human breast adenocarcinoma cells and demonstrate selective cytotoxicity against this type of cancer cells. Using fluorescent human breast adenocarcinoma xenograft models, the possibility of intravital visualization of the UCNP-based complexes biodistribution and accumulation in tumor was demonstrated.

Cite

CITATION STYLE

APA

Guryev, E. L., Smyshlyaeva, A. S., Shilyagina, N. Y., Sokolova, E. A., Shanwar, S., Kostyuk, A. B., … Zvyagin, A. V. (2020). UCNP-based photoluminescent nanomedicines for targeted imaging and theranostics of cancer. Molecules, 25(18). https://doi.org/10.3390/molecules25184302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free